Literature DB >> 28496692

Head Up Tilt Testing: An Appraisal of Its Current Role in the Management of Patients with Syncope.

Paula Macedo1, Luiz Roberto Leite1, Samuel J Asirvatham1,2, Denise Tessariol Hachul1, Leopoldo Luiz Dos Santos-Neto1, Win-Kuang Shen1.   

Abstract

Head up tilt testing (HTT) is now commonly used to investigate otherwise unexplained syncope and presyncope. This test has been used for over 20 years primarily to diagnose neurally mediated syncope, but HTT's exact role in the diagnostic process remains uncertain. Recognized limitations include poor reproducibility, lack of prognostic role, and insufficient randomized studies to guide therapeutic choice. In this review, we describe the indications and methods recommended by present guidelines on utilizing HTT. In addition, present criticisms and limitations of this test, along with future perspectives, are outlined.

Entities:  

Year:  2011        PMID： 28496692      PMCID： PMC5153047          DOI： 10.4022/jafib.333

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  56 in total

1.  Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol.

Authors:  A G Hermosillo; M F Marquez; K Jauregui-Renaud; J C Falcon; J M Casanova; M Guevara; M Cardenas
Journal:  Acta Cardiol       Date:  2000-12       Impact factor: 1.718

2.  Prevalence and triggers of syncope in medical students.

Authors:  Karin S Ganzeboom; Nancy Colman; Johannes B Reitsma; Win K Shen; Wouter Wieling
Journal:  Am J Cardiol       Date:  2003-04-15       Impact factor: 2.778

Review 3.  Nitrate stimulated tilt table testing: a review of the literature.

Authors:  Arnaud J J Aerts
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

4.  The ACCF/AHA scientific statement on syncope needs rethinking.

Authors:  David G Benditt; Brian Olshansky; Wouter Wieling
Journal:  J Am Coll Cardiol       Date:  2006-11-22       Impact factor: 24.094

Review 5.  A review of postural orthostatic tachycardia syndrome.

Authors:  Sheila Carew; Margaret O Connor; John Cooke; Richard Conway; Christine Sheehy; Aine Costelloe; Declan Lyons
Journal:  Europace       Date:  2009-01       Impact factor: 5.214

6.  Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope.

Authors:  A Aerts; P Dendale; G Strobel; P Block
Journal:  Am Heart J       Date:  1997-05       Impact factor: 4.749

7.  Head-up tilt testing potentiated with oral nitroglycerin: a randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope.

Authors:  A Bartoletti; G Gaggioli; C Menozzi; N Bottoni; A Del Rosso; R Mureddu; G Musso; G Foglia-Manzillo; B Bonfigli; M Brignole
Journal:  Europace       Date:  1999-07       Impact factor: 5.214

8.  Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.

Authors:  A H Madrid; J Ortega; J G Rebollo; J G Manzano; J G Segovia; A Sánchez; G Peña; C Moro
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

9.  An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test.

Authors:  Jean-Claude Deharo; Christophe Jego; André Lanteaume; Pierre Djiane
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

10.  Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.

Authors:  A Del Rosso; P Bartoli; A Bartoletti; A Brandinelli-Geri; F Bonechi; M Maioli; F Mazza; A Michelucci; L Russo; E Salvetti; M Sansoni; A Zipoli; A Fierro; A Ieri
Journal:  Am Heart J       Date:  1998-04       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.